Overview
Exit Award only
Students on the MSc (Clinical Pharmacy) programme successfully completing 60 credits (taught modules) may opt not to proceed to the Dissertation (PF6008) and may opt to be conferred with a Postgraduate Diploma in Clinical Pharmacy. A student who subsequently applies to continue to the Master's Degree in Clinical Pharmacy must do so within 5 years from the date of successful completion of the Diploma examinations.
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
Module List
| Code |
Title |
Credits |
| |
| PF6001 | Biostatistics/Critical Appraisal | 5 |
| PF6005 | Pharmacoeconomics | 5 |
| PF6006 | Pharmacotherapy II: Endocrinology, CNS, Musculoskeletal and Infectious Disease | 15 |
| PF6007 | Pharmacotherapy III: Special Populations | 10 |
| PF6009 | Pharmacotherapy I: Renal, CVS, Respiratory and Gastrointestinal Diseases | 15 |
| PF6010 | Drugs and Therapeutics: Safety, Efficacy and Rational Use | 10 |
| Total Credits | 60 |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for Postgraduate Diploma in Clinical Pharmacy (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
1
1-1
Discuss and explain the epidemiology, aetiology, pathophysiology, signs, symptoms, and tests leading to the diagnosis of common disorders/diseases of the various physiological systems;
1-2
2
Choose the most appropriate and effective therapy for selected diseases of the various physiological systems, using a personalised approach to pharmaceutical care;
1-3
3
Monitor and counsel the patient on the use of the recommended therapies and health promotion;
1-4
4
Formulate pharmaceutical care plans and counsel patients including patients with co-morbid disease;
1-5
5
Apply the principles of health economics, economic modelling, Quality Adjusted Life Year (QALY's) sensitivity analysis for use in the health care system;
1-6
6
Apply the principles of clinical pharmacokinetics, therapeutic drug monitoring and pharmacogenetics to medicines management to individualise patient care;
1-7
7
Outline the role of the pharmacist in risk management processes, including the promotion of medication safety, the rational use of medicines and in pharmacovigilance;
1-8
8
Demonstrate knowledge of trial designs and the statistical methods involved in evaluating study findings and critically appraise these in research papers;
12-1
9
Effectively communicate and justify decisions.
